195 related articles for article (PubMed ID: 8647574)
21. Effect of preprocedural statin use on procedural myocardial infarction and major cardiac adverse events in percutaneous coronary intervention: a meta-analysis.
Ebrahimi R; Saleh J; Toggart E; Shah AP; Azmoon S; Babaei H; Lee J; Smith R; Movahed MR; Rubin SA
J Invasive Cardiol; 2008 Jun; 20(6):292-5. PubMed ID: 18523323
[TBL] [Abstract][Full Text] [Related]
22. A prospective study of pravastatin in the elderly at risk: new hope for older persons.
Shepherd J
Am J Geriatr Cardiol; 2004; 13(3 Suppl 1):17-24. PubMed ID: 15133425
[TBL] [Abstract][Full Text] [Related]
23. Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial.
Thompson PL; Meredith I; Amerena J; Campbell TJ; Sloman JG; Harris PJ;
Am Heart J; 2004 Jul; 148(1):e2. PubMed ID: 15215811
[TBL] [Abstract][Full Text] [Related]
24. The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials.
Holdaas H; Wanner C; Abletshauser C; Gimpelewicz C; Isaacsohn J
Int J Cardiol; 2007 Apr; 117(1):64-74. PubMed ID: 16889855
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
26. Reduction in coronary events during treatment with pravastatin. PLAC I and PLAC II Investigators. Pravastatin Limitation of Atherosclerosis in the Coronary Arteries.
Furberg CD; Pitt B; Byington RP; Park JS; McGovern ME
Am J Cardiol; 1995 Sep; 76(9):60C-63C. PubMed ID: 7572689
[TBL] [Abstract][Full Text] [Related]
27. Pravastatin therapy and the risk of stroke.
White HD; Simes RJ; Anderson NE; Hankey GJ; Watson JD; Hunt D; Colquhoun DM; Glasziou P; MacMahon S; Kirby AC; West MJ; Tonkin AM
N Engl J Med; 2000 Aug; 343(5):317-26. PubMed ID: 10922421
[TBL] [Abstract][Full Text] [Related]
28. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial.
Hunt D; Young P; Simes J; Hague W; Mann S; Owensby D; Lane G; Tonkin A
Ann Intern Med; 2001 May; 134(10):931-40. PubMed ID: 11352694
[TBL] [Abstract][Full Text] [Related]
29. Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study.
Söderberg S; Colquhoun D; Keech A; Yallop J; Barnes EH; Pollicino C; Simes J; Tonkin AM; Nestel P;
Int J Obes (Lond); 2009 Jan; 33(1):123-30. PubMed ID: 19050671
[TBL] [Abstract][Full Text] [Related]
30. Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.
Lewis SJ; Sacks FM; Mitchell JS; East C; Glasser S; Kell S; Letterer R; Limacher M; Moye LA; Rouleau JL; Pfeffer MA; Braunwald E
J Am Coll Cardiol; 1998 Jul; 32(1):140-6. PubMed ID: 9669262
[TBL] [Abstract][Full Text] [Related]
31. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.
Lewis SJ; Moye LA; Sacks FM; Johnstone DE; Timmis G; Mitchell J; Limacher M; Kell S; Glasser SP; Grant J; Davis BR; Pfeffer MA; Braunwald E
Ann Intern Med; 1998 Nov; 129(9):681-9. PubMed ID: 9841599
[TBL] [Abstract][Full Text] [Related]
32. Evidence for the benefit of early intervention with pravastatin for secondary prevention of cardiovascular events.
Arntz HR
Atherosclerosis; 1999 Sep; 147 Suppl 1():S17-21. PubMed ID: 10575058
[TBL] [Abstract][Full Text] [Related]
33. Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators.
Marschner IC; Colquhoun D; Simes RJ; Glasziou P; Harris P; Singh BB; Friedlander D; White H; Thompson P; Tonkin A;
J Am Coll Cardiol; 2001 Jul; 38(1):56-63. PubMed ID: 11451296
[TBL] [Abstract][Full Text] [Related]
34. [Statins and cerebrovascular events].
Auer J; Berent R; Eber B
Herz; 2002 Dec; 27(8):765-71. PubMed ID: 12574894
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study.
Hague WE; Simes J; Kirby A; Keech AC; White HD; Hunt D; Nestel PJ; Colquhoun DM; Pater H; Stewart RA; Sullivan DR; Thompson PL; West M; Glasziou PP; Tonkin AM;
Circulation; 2016 May; 133(19):1851-60. PubMed ID: 27016105
[TBL] [Abstract][Full Text] [Related]
36. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.
Sacks FM; Pfeffer MA; Moye LA; Rouleau JL; Rutherford JD; Cole TG; Brown L; Warnica JW; Arnold JM; Wun CC; Davis BR; Braunwald E
N Engl J Med; 1996 Oct; 335(14):1001-9. PubMed ID: 8801446
[TBL] [Abstract][Full Text] [Related]
37. Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: a report from the Regression Growth Evaluation Statin Study.
de Groot E; Jukema JW; van Boven AJ; Reiber JH; Zwinderman AH; Lie KI; Ackerstaff RA; Bruschke AV
Am J Cardiol; 1995 Sep; 76(9):40C-46C. PubMed ID: 7572685
[TBL] [Abstract][Full Text] [Related]
38. Statins and secondary prevention of coronary heart disease.
Ahmed M; Griffiths P
Br J Community Nurs; 2004 Apr; 9(4):160-5. PubMed ID: 15150487
[TBL] [Abstract][Full Text] [Related]
39. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation.
Pitt B; Mancini GB; Ellis SG; Rosman HS; Park JS; McGovern ME
J Am Coll Cardiol; 1995 Nov; 26(5):1133-9. PubMed ID: 7594023
[TBL] [Abstract][Full Text] [Related]
40. Statin lipid-lowering therapy for acute myocardial infarction and unstable angina: efficacy and mechanism of benefit.
Wright RS; Murphy JG; Bybee KA; Kopecky SL; LaBlanche JM
Mayo Clin Proc; 2002 Oct; 77(10):1085-92. PubMed ID: 12374252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
